Skip to main content
Top

2022 | OriginalPaper | Chapter

Solid Lipid Nanoparticles Containing Berberine by Spray-Drying Method

Authors : Mai Chau-Ngoc Nguyen, Khoa Nguyen-Manh Le, Ngan Thi-Thu Huynh, Tham Thi-Thanh Nguyen, Hoa Thi-Xuan Bui, Van Hong Nguyen

Published in: 8th International Conference on the Development of Biomedical Engineering in Vietnam

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Berberine is commonly used in Eastern countries due to its various biological activities and low cost. However, low permeability has limited its bioavailability. This study was conducted to fabricate solid lipid nanoparticles (SLNs) containing berberine by spray-drying method to enhance its absorption in the human body. SLNs containing berberine was prepared by stearic acid as a solid lipid base and various surfactants. Then, the aqueous dispersion of SLNs was converted into powders to be stored over a long time by the spray-drying method with carbohydrate carriers. The spray-drying parameters such as the inlet and outlet temperatures, the blower speed, the atomizing pressure, the feeding rate were optimized. The nanoparticles physicochemical properties were evaluated before and after the spraying process. The lipid nanoparticles containing berberine were successfully prepared by the spray-drying method with a small particle size (around 230 nm), zeta potential (approximately −30 mV), and homogenous dispersion (polydispersity index just above 0.12). The optimized spray drying parameters were Tinlet/outlet of 110/65 °C, the blower of 0.58 m3/min, atomizing of 20 kPa, and feeding rate of 0.1 L/h. The resulted SLNs exhibited good physical stability and redispersion. The collected SLNs by spray-drying could be considered a potential drug delivery system to enhance berberine absorption into our human body.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Mehnert W, Mader K (2012) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 64:83–101CrossRef Mehnert W, Mader K (2012) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 64:83–101CrossRef
2.
go back to reference Freitas C, Muller RH (1999) Correlation between long-term stability of solid lipid nanoparticles (SLNTM) and crystallinity of the lipid phase. Eur J Pharm Biopharm 47(2):125–132CrossRef Freitas C, Muller RH (1999) Correlation between long-term stability of solid lipid nanoparticles (SLNTM) and crystallinity of the lipid phase. Eur J Pharm Biopharm 47(2):125–132CrossRef
3.
go back to reference Muller RH, Runge SA (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery. Submicron Emulsions Drug targeting Delivery 22:219–234 Muller RH, Runge SA (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery. Submicron Emulsions Drug targeting Delivery 22:219–234
4.
go back to reference Eldem T, Speiser P, Hincal A (1991) Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 8(1):47–51CrossRef Eldem T, Speiser P, Hincal A (1991) Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 8(1):47–51CrossRef
5.
go back to reference Speiser P (1990) Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 167825, 0167825 Speiser P (1990) Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 167825, 0167825
6.
go back to reference Muller RH, Shegokar R, Keck MC (2011) 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr Drug Discovery Technol 8(3):207–227 Muller RH, Shegokar R, Keck MC (2011) 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr Drug Discovery Technol 8(3):207–227
7.
go back to reference Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez Gascón A (2013) Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors. Eur J Pharm Biopharm 84(2):309–314 Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez Gascón A (2013) Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors. Eur J Pharm Biopharm 84(2):309–314
8.
go back to reference Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V (2013) Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Controlled Release 166(2):115–123 Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V (2013) Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Controlled Release 166(2):115–123
9.
go back to reference Keck CM, Hommoss A, Muller RH (2008) Lipid nanoparticles (SLN, NLC, LDC) for the enhancement of oral absorption. In: Walker RB, Hadgraft J, Roberts MS, Lane ME (eds) Modified release drug delivery systems, vol 1, 2nd ed, pp 269–286 Keck CM, Hommoss A, Muller RH (2008) Lipid nanoparticles (SLN, NLC, LDC) for the enhancement of oral absorption. In: Walker RB, Hadgraft J, Roberts MS, Lane ME (eds) Modified release drug delivery systems, vol 1, 2nd ed, pp 269–286
10.
go back to reference Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177CrossRef Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177CrossRef
11.
go back to reference Corrias F, Lai F (2011) New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul 5(3):201–213CrossRef Corrias F, Lai F (2011) New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul 5(3):201–213CrossRef
12.
go back to reference Ricci M, Puglia C, Bonina F, Di Giovanni C, Giovagnoli S, Rossi C (2005) Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci 94(5):1149–1159CrossRef Ricci M, Puglia C, Bonina F, Di Giovanni C, Giovagnoli S, Rossi C (2005) Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci 94(5):1149–1159CrossRef
13.
go back to reference Freitas C, Lucks JS, Müller RH (1994) P238 effect of storage conditions on long-term stability of “solid lipid nanoparticles” (SLN) in aqueous dispersion. Eur J Pharm Sci 2(1–2):178CrossRef Freitas C, Lucks JS, Müller RH (1994) P238 effect of storage conditions on long-term stability of “solid lipid nanoparticles” (SLN) in aqueous dispersion. Eur J Pharm Sci 2(1–2):178CrossRef
14.
go back to reference Broadhead J, Edmond Rouan SK, Rhodes CT (1992) The spray drying of pharmaceuticals. Drug Dev Ind Pharm 18(11–12):1169–1206CrossRef Broadhead J, Edmond Rouan SK, Rhodes CT (1992) The spray drying of pharmaceuticals. Drug Dev Ind Pharm 18(11–12):1169–1206CrossRef
15.
go back to reference Freag MS, Saleh WM, Abdallah OY (2018) Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohyd Polym 188:108–120CrossRef Freag MS, Saleh WM, Abdallah OY (2018) Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohyd Polym 188:108–120CrossRef
16.
go back to reference Yu F, Ao M, Zheng X, Li N, Xia J, Li Y et al (2017) PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv 24(1):825–833 Yu F, Ao M, Zheng X, Li N, Xia J, Li Y et al (2017) PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv 24(1):825–833
17.
go back to reference Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F et al (2014) Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod 77(4):766–772 Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F et al (2014) Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod 77(4):766–772
18.
go back to reference Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S (2010) Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech 11(3):1466–1475CrossRef Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S (2010) Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech 11(3):1466–1475CrossRef
19.
go back to reference Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22(8):999–1012CrossRef Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22(8):999–1012CrossRef
20.
go back to reference Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011) RETRACTED: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2and prostaglandin E2receptors. Carcinogenesis 32(1):86–92CrossRef Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011) RETRACTED: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2and prostaglandin E2receptors. Carcinogenesis 32(1):86–92CrossRef
21.
go back to reference Birdsall TC (1997) Berberine: therapeutic potential of alkaloid found in several medicinal plants. Altern Med Rev 2:94–103 Birdsall TC (1997) Berberine: therapeutic potential of alkaloid found in several medicinal plants. Altern Med Rev 2:94–103
22.
go back to reference Kulkarni SK, Dandiya PC, Varandani NL (1972) Pharmacological investigations of berberine sulphate. Jpn J Pharmacol 22(1):11–16CrossRef Kulkarni SK, Dandiya PC, Varandani NL (1972) Pharmacological investigations of berberine sulphate. Jpn J Pharmacol 22(1):11–16CrossRef
23.
go back to reference Huang CG, Chu ZL, Yang ZM (1991) Effects of berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits. Zhongguo yao li xue bao Acta pharmacologica Sinica 12(6):526 Huang CG, Chu ZL, Yang ZM (1991) Effects of berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits. Zhongguo yao li xue bao Acta pharmacologica Sinica 12(6):526
24.
go back to reference Salminen H, Ankenbrand J, Zeeb B, Bönisch GB, Schäfer C, Kohlus R, Weiss J (2019) Influence of spray drying on the stability of food-grade solid lipid nanoparticles. Food Res Int 119:741–750CrossRef Salminen H, Ankenbrand J, Zeeb B, Bönisch GB, Schäfer C, Kohlus R, Weiss J (2019) Influence of spray drying on the stability of food-grade solid lipid nanoparticles. Food Res Int 119:741–750CrossRef
26.
go back to reference Eskandarloo H, Badiei A, Behnajady MA, Ziarani GM (2016) Ultrasonic-assisted degradation of phenazopyridine with a combination of Sm-doped ZnO nanoparticles and inorganic oxidants. Ultrason Sonochem 28:169–177CrossRef Eskandarloo H, Badiei A, Behnajady MA, Ziarani GM (2016) Ultrasonic-assisted degradation of phenazopyridine with a combination of Sm-doped ZnO nanoparticles and inorganic oxidants. Ultrason Sonochem 28:169–177CrossRef
27.
go back to reference Hao H, Wu M, Chen Y, Tang J, Wu Q (2004) Cavitation mechanism in cyanobacterial growth inhibition by ultrasonic irradiation. Colloids Surf, B 33(3–4):151–156CrossRef Hao H, Wu M, Chen Y, Tang J, Wu Q (2004) Cavitation mechanism in cyanobacterial growth inhibition by ultrasonic irradiation. Colloids Surf, B 33(3–4):151–156CrossRef
28.
go back to reference Panariti A, Miserocchi G, Rivolta I (2012) The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl 5:87 Panariti A, Miserocchi G, Rivolta I (2012) The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl 5:87
29.
go back to reference Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377(1):159–169CrossRef Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377(1):159–169CrossRef
30.
go back to reference Müller RH, Mehnert W, Lucks JS, Schwarz C, Zur Mühlen A (1995) Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41(1):62–69 Müller RH, Mehnert W, Lucks JS, Schwarz C, Zur Mühlen A (1995) Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41(1):62–69
31.
go back to reference Mudalige T, Qu H, Van Haute D, Ansar SM, Paredes A, Ingle T (2019) Characterization of nanomaterials: tools and challenges. In: Nanomaterials for food applications. Elsevier, Amsterdam, pp 313–353 Mudalige T, Qu H, Van Haute D, Ansar SM, Paredes A, Ingle T (2019) Characterization of nanomaterials: tools and challenges. In: Nanomaterials for food applications. Elsevier, Amsterdam, pp 313–353
32.
go back to reference Jain R, Savla H, Naik I, Maniar J, Punjabi K, Vaidya S, Menon M (2018) Novel nanotechnology based delivery systems for chemotherapy and prophylaxis of tuberculosis. In: Handbook of nanomaterials for industrial applications. Elsevier, Amsterdam, pp 587–620 Jain R, Savla H, Naik I, Maniar J, Punjabi K, Vaidya S, Menon M (2018) Novel nanotechnology based delivery systems for chemotherapy and prophylaxis of tuberculosis. In: Handbook of nanomaterials for industrial applications. Elsevier, Amsterdam, pp 587–620
33.
go back to reference Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70(2):633–640CrossRef Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70(2):633–640CrossRef
34.
go back to reference Müller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1–2):121–128CrossRef Müller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1–2):121–128CrossRef
35.
go back to reference Freitas C, Müller RH (1998) Spray-drying of solid lipid nanoparticles (SLNTM). Eur J Pharm Biopharm 46(2):145–151CrossRef Freitas C, Müller RH (1998) Spray-drying of solid lipid nanoparticles (SLNTM). Eur J Pharm Biopharm 46(2):145–151CrossRef
Metadata
Title
Solid Lipid Nanoparticles Containing Berberine by Spray-Drying Method
Authors
Mai Chau-Ngoc Nguyen
Khoa Nguyen-Manh Le
Ngan Thi-Thu Huynh
Tham Thi-Thanh Nguyen
Hoa Thi-Xuan Bui
Van Hong Nguyen
Copyright Year
2022
DOI
https://doi.org/10.1007/978-3-030-75506-5_25

Premium Partner